anti human Search Results


goat anti human igg h l secondary antibody  (Novus Biologicals)
93
Novus Biologicals goat anti human igg h l secondary antibody
Goat Anti Human Igg H L Secondary Antibody, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/goat anti human igg h l secondary antibody/product/Novus Biologicals
Average 93 stars, based on 1 article reviews
goat anti human igg h l secondary antibody - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier
h1915  (R&D Systems)
93
R&D Systems h1915
YAP1 status does not predict sensitivity to cisplatin in LCNEC cell lines (A) or cell line/PDX xenograft models (B). C, Treatment of LCNEC cell lines with DMSO, cisplatin, MYF-01-37, XAV-939 and decitabine did not change YAP1, but verteporfin reduced YAP1 levels. D, YAP1 status does not predict response to verteporfin. E, Waterfall plot of drug sensitivity in LCNEC cell lines. A comparison of high YAP1 levels and IC50 values identified several drugs with similar targets, including MEK1/2, CDK4/6, and Src family kinase inhibitors. F, Treatment of YAP1-high LCNEC and SCLC (SW1271) cell lines with trametinib did not change YAP1 levels. G, Tumor growth curves from YAP1-high cell line xenografts <t>H1915</t> (LCNEC) and SW1271 (SCLC) demonstrate a delay in tumor growth with trametinib treatment.
H1915, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/h1915/product/R&D Systems
Average 93 stars, based on 1 article reviews
h1915 - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier
donkey anti human alexa fluor 647  (Jackson Immuno)
93
Jackson Immuno donkey anti human alexa fluor 647
YAP1 status does not predict sensitivity to cisplatin in LCNEC cell lines (A) or cell line/PDX xenograft models (B). C, Treatment of LCNEC cell lines with DMSO, cisplatin, MYF-01-37, XAV-939 and decitabine did not change YAP1, but verteporfin reduced YAP1 levels. D, YAP1 status does not predict response to verteporfin. E, Waterfall plot of drug sensitivity in LCNEC cell lines. A comparison of high YAP1 levels and IC50 values identified several drugs with similar targets, including MEK1/2, CDK4/6, and Src family kinase inhibitors. F, Treatment of YAP1-high LCNEC and SCLC (SW1271) cell lines with trametinib did not change YAP1 levels. G, Tumor growth curves from YAP1-high cell line xenografts <t>H1915</t> (LCNEC) and SW1271 (SCLC) demonstrate a delay in tumor growth with trametinib treatment.
Donkey Anti Human Alexa Fluor 647, supplied by Jackson Immuno, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/donkey anti human alexa fluor 647/product/Jackson Immuno
Average 93 stars, based on 1 article reviews
donkey anti human alexa fluor 647 - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier
anti fibroblast beads  (Miltenyi Biotec)
95
Miltenyi Biotec anti fibroblast beads
YAP1 status does not predict sensitivity to cisplatin in LCNEC cell lines (A) or cell line/PDX xenograft models (B). C, Treatment of LCNEC cell lines with DMSO, cisplatin, MYF-01-37, XAV-939 and decitabine did not change YAP1, but verteporfin reduced YAP1 levels. D, YAP1 status does not predict response to verteporfin. E, Waterfall plot of drug sensitivity in LCNEC cell lines. A comparison of high YAP1 levels and IC50 values identified several drugs with similar targets, including MEK1/2, CDK4/6, and Src family kinase inhibitors. F, Treatment of YAP1-high LCNEC and SCLC (SW1271) cell lines with trametinib did not change YAP1 levels. G, Tumor growth curves from YAP1-high cell line xenografts <t>H1915</t> (LCNEC) and SW1271 (SCLC) demonstrate a delay in tumor growth with trametinib treatment.
Anti Fibroblast Beads, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti fibroblast beads/product/Miltenyi Biotec
Average 95 stars, based on 1 article reviews
anti fibroblast beads - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier
cd11b  (Miltenyi Biotec)
95
Miltenyi Biotec cd11b
YAP1 status does not predict sensitivity to cisplatin in LCNEC cell lines (A) or cell line/PDX xenograft models (B). C, Treatment of LCNEC cell lines with DMSO, cisplatin, MYF-01-37, XAV-939 and decitabine did not change YAP1, but verteporfin reduced YAP1 levels. D, YAP1 status does not predict response to verteporfin. E, Waterfall plot of drug sensitivity in LCNEC cell lines. A comparison of high YAP1 levels and IC50 values identified several drugs with similar targets, including MEK1/2, CDK4/6, and Src family kinase inhibitors. F, Treatment of YAP1-high LCNEC and SCLC (SW1271) cell lines with trametinib did not change YAP1 levels. G, Tumor growth curves from YAP1-high cell line xenografts <t>H1915</t> (LCNEC) and SW1271 (SCLC) demonstrate a delay in tumor growth with trametinib treatment.
Cd11b, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd11b/product/Miltenyi Biotec
Average 95 stars, based on 1 article reviews
cd11b - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier
goat anti rabbit immunoglobulin  (Bio-Rad)
93
Bio-Rad goat anti rabbit immunoglobulin
YAP1 status does not predict sensitivity to cisplatin in LCNEC cell lines (A) or cell line/PDX xenograft models (B). C, Treatment of LCNEC cell lines with DMSO, cisplatin, MYF-01-37, XAV-939 and decitabine did not change YAP1, but verteporfin reduced YAP1 levels. D, YAP1 status does not predict response to verteporfin. E, Waterfall plot of drug sensitivity in LCNEC cell lines. A comparison of high YAP1 levels and IC50 values identified several drugs with similar targets, including MEK1/2, CDK4/6, and Src family kinase inhibitors. F, Treatment of YAP1-high LCNEC and SCLC (SW1271) cell lines with trametinib did not change YAP1 levels. G, Tumor growth curves from YAP1-high cell line xenografts <t>H1915</t> (LCNEC) and SW1271 (SCLC) demonstrate a delay in tumor growth with trametinib treatment.
Goat Anti Rabbit Immunoglobulin, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/goat anti rabbit immunoglobulin/product/Bio-Rad
Average 93 stars, based on 1 article reviews
goat anti rabbit immunoglobulin - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier
horseradish peroxidase conjugated goat anti rabbit  (Bio-Rad)
95
Bio-Rad horseradish peroxidase conjugated goat anti rabbit
YAP1 status does not predict sensitivity to cisplatin in LCNEC cell lines (A) or cell line/PDX xenograft models (B). C, Treatment of LCNEC cell lines with DMSO, cisplatin, MYF-01-37, XAV-939 and decitabine did not change YAP1, but verteporfin reduced YAP1 levels. D, YAP1 status does not predict response to verteporfin. E, Waterfall plot of drug sensitivity in LCNEC cell lines. A comparison of high YAP1 levels and IC50 values identified several drugs with similar targets, including MEK1/2, CDK4/6, and Src family kinase inhibitors. F, Treatment of YAP1-high LCNEC and SCLC (SW1271) cell lines with trametinib did not change YAP1 levels. G, Tumor growth curves from YAP1-high cell line xenografts <t>H1915</t> (LCNEC) and SW1271 (SCLC) demonstrate a delay in tumor growth with trametinib treatment.
Horseradish Peroxidase Conjugated Goat Anti Rabbit, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/horseradish peroxidase conjugated goat anti rabbit/product/Bio-Rad
Average 95 stars, based on 1 article reviews
horseradish peroxidase conjugated goat anti rabbit - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier
mouse anti hprl monoclonal antibodies mab  (Bio-Rad)
88
Bio-Rad mouse anti hprl monoclonal antibodies mab
YAP1 status does not predict sensitivity to cisplatin in LCNEC cell lines (A) or cell line/PDX xenograft models (B). C, Treatment of LCNEC cell lines with DMSO, cisplatin, MYF-01-37, XAV-939 and decitabine did not change YAP1, but verteporfin reduced YAP1 levels. D, YAP1 status does not predict response to verteporfin. E, Waterfall plot of drug sensitivity in LCNEC cell lines. A comparison of high YAP1 levels and IC50 values identified several drugs with similar targets, including MEK1/2, CDK4/6, and Src family kinase inhibitors. F, Treatment of YAP1-high LCNEC and SCLC (SW1271) cell lines with trametinib did not change YAP1 levels. G, Tumor growth curves from YAP1-high cell line xenografts <t>H1915</t> (LCNEC) and SW1271 (SCLC) demonstrate a delay in tumor growth with trametinib treatment.
Mouse Anti Hprl Monoclonal Antibodies Mab, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 88/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse anti hprl monoclonal antibodies mab/product/Bio-Rad
Average 88 stars, based on 1 article reviews
mouse anti hprl monoclonal antibodies mab - by Bioz Stars, 2026-03
88/100 stars
  Buy from Supplier
human serum  (Thermo Fisher)
99
Thermo Fisher human serum
YAP1 status does not predict sensitivity to cisplatin in LCNEC cell lines (A) or cell line/PDX xenograft models (B). C, Treatment of LCNEC cell lines with DMSO, cisplatin, MYF-01-37, XAV-939 and decitabine did not change YAP1, but verteporfin reduced YAP1 levels. D, YAP1 status does not predict response to verteporfin. E, Waterfall plot of drug sensitivity in LCNEC cell lines. A comparison of high YAP1 levels and IC50 values identified several drugs with similar targets, including MEK1/2, CDK4/6, and Src family kinase inhibitors. F, Treatment of YAP1-high LCNEC and SCLC (SW1271) cell lines with trametinib did not change YAP1 levels. G, Tumor growth curves from YAP1-high cell line xenografts <t>H1915</t> (LCNEC) and SW1271 (SCLC) demonstrate a delay in tumor growth with trametinib treatment.
Human Serum, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human serum/product/Thermo Fisher
Average 99 stars, based on 1 article reviews
human serum - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier
horseradish peroxidase conjugated goat anti human igg  (SouthernBiotech)
97
SouthernBiotech horseradish peroxidase conjugated goat anti human igg
YAP1 status does not predict sensitivity to cisplatin in LCNEC cell lines (A) or cell line/PDX xenograft models (B). C, Treatment of LCNEC cell lines with DMSO, cisplatin, MYF-01-37, XAV-939 and decitabine did not change YAP1, but verteporfin reduced YAP1 levels. D, YAP1 status does not predict response to verteporfin. E, Waterfall plot of drug sensitivity in LCNEC cell lines. A comparison of high YAP1 levels and IC50 values identified several drugs with similar targets, including MEK1/2, CDK4/6, and Src family kinase inhibitors. F, Treatment of YAP1-high LCNEC and SCLC (SW1271) cell lines with trametinib did not change YAP1 levels. G, Tumor growth curves from YAP1-high cell line xenografts <t>H1915</t> (LCNEC) and SW1271 (SCLC) demonstrate a delay in tumor growth with trametinib treatment.
Horseradish Peroxidase Conjugated Goat Anti Human Igg, supplied by SouthernBiotech, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/horseradish peroxidase conjugated goat anti human igg/product/SouthernBiotech
Average 97 stars, based on 1 article reviews
horseradish peroxidase conjugated goat anti human igg - by Bioz Stars, 2026-03
97/100 stars
  Buy from Supplier
monoclonal anti tgf b1 antibody  (Bio-Rad)
93
Bio-Rad monoclonal anti tgf b1 antibody
YAP1 status does not predict sensitivity to cisplatin in LCNEC cell lines (A) or cell line/PDX xenograft models (B). C, Treatment of LCNEC cell lines with DMSO, cisplatin, MYF-01-37, XAV-939 and decitabine did not change YAP1, but verteporfin reduced YAP1 levels. D, YAP1 status does not predict response to verteporfin. E, Waterfall plot of drug sensitivity in LCNEC cell lines. A comparison of high YAP1 levels and IC50 values identified several drugs with similar targets, including MEK1/2, CDK4/6, and Src family kinase inhibitors. F, Treatment of YAP1-high LCNEC and SCLC (SW1271) cell lines with trametinib did not change YAP1 levels. G, Tumor growth curves from YAP1-high cell line xenografts <t>H1915</t> (LCNEC) and SW1271 (SCLC) demonstrate a delay in tumor growth with trametinib treatment.
Monoclonal Anti Tgf B1 Antibody, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/monoclonal anti tgf b1 antibody/product/Bio-Rad
Average 93 stars, based on 1 article reviews
monoclonal anti tgf b1 antibody - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier
anti human fab  (Gator Bio Inc)
94
Gator Bio Inc anti human fab
YAP1 status does not predict sensitivity to cisplatin in LCNEC cell lines (A) or cell line/PDX xenograft models (B). C, Treatment of LCNEC cell lines with DMSO, cisplatin, MYF-01-37, XAV-939 and decitabine did not change YAP1, but verteporfin reduced YAP1 levels. D, YAP1 status does not predict response to verteporfin. E, Waterfall plot of drug sensitivity in LCNEC cell lines. A comparison of high YAP1 levels and IC50 values identified several drugs with similar targets, including MEK1/2, CDK4/6, and Src family kinase inhibitors. F, Treatment of YAP1-high LCNEC and SCLC (SW1271) cell lines with trametinib did not change YAP1 levels. G, Tumor growth curves from YAP1-high cell line xenografts <t>H1915</t> (LCNEC) and SW1271 (SCLC) demonstrate a delay in tumor growth with trametinib treatment.
Anti Human Fab, supplied by Gator Bio Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti human fab/product/Gator Bio Inc
Average 94 stars, based on 1 article reviews
anti human fab - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

Image Search Results


YAP1 status does not predict sensitivity to cisplatin in LCNEC cell lines (A) or cell line/PDX xenograft models (B). C, Treatment of LCNEC cell lines with DMSO, cisplatin, MYF-01-37, XAV-939 and decitabine did not change YAP1, but verteporfin reduced YAP1 levels. D, YAP1 status does not predict response to verteporfin. E, Waterfall plot of drug sensitivity in LCNEC cell lines. A comparison of high YAP1 levels and IC50 values identified several drugs with similar targets, including MEK1/2, CDK4/6, and Src family kinase inhibitors. F, Treatment of YAP1-high LCNEC and SCLC (SW1271) cell lines with trametinib did not change YAP1 levels. G, Tumor growth curves from YAP1-high cell line xenografts H1915 (LCNEC) and SW1271 (SCLC) demonstrate a delay in tumor growth with trametinib treatment.

Journal: bioRxiv

Article Title: YAP1 status defines two intrinsic subtypes of LCNEC with distinct molecular features and therapeutic vulnerabilities

doi: 10.1101/2023.12.19.572449

Figure Lengend Snippet: YAP1 status does not predict sensitivity to cisplatin in LCNEC cell lines (A) or cell line/PDX xenograft models (B). C, Treatment of LCNEC cell lines with DMSO, cisplatin, MYF-01-37, XAV-939 and decitabine did not change YAP1, but verteporfin reduced YAP1 levels. D, YAP1 status does not predict response to verteporfin. E, Waterfall plot of drug sensitivity in LCNEC cell lines. A comparison of high YAP1 levels and IC50 values identified several drugs with similar targets, including MEK1/2, CDK4/6, and Src family kinase inhibitors. F, Treatment of YAP1-high LCNEC and SCLC (SW1271) cell lines with trametinib did not change YAP1 levels. G, Tumor growth curves from YAP1-high cell line xenografts H1915 (LCNEC) and SW1271 (SCLC) demonstrate a delay in tumor growth with trametinib treatment.

Article Snippet: One million cells each for H810, H1155, H1755, H1833, H2106, MKL1, HCC2374, HCC4017, HOP92, H1359, H2066, H1770, H2106, H1570, H661, HCC3051, H460, HCC4017, H1299, and H1915 in triplicate were surfaced stained with DLL3 (FAB4315P; R&D Systems), AXL (386202; Biolegends), CD56 (362534), EPCAM (324222) or IgG control and then fixed in 2% PFA.

Techniques: Comparison